Hemenway Trust Co LLC
BankPosition in APUS — Apimeds Pharmaceuticals US, Inc.
CIK 1494234
SALEM, NH
Position in APUS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$246,600
-$243,586 QoQ
Shares Held
27,400
0.0% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 7 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APUS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hemenway Trust Co LLC holds $246,600 across 1 Drug Manufacturers - Specialty & Generic name. APUS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APUS |
Apimeds Pharmaceuticals US, Inc.
This page
|
27,400 | $246,600 |
All Filings in APUS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,600 | 274,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $490,186 | 274,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | — | 274,000 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | — | 250,000 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||